オーソバイオロジクスの世界市場予測（～2022年）：関節内補充療法、合成オーソバイオロジクス、DBM、BMP、PRP、BMAC、同種移植片...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKETS COVERED 14
1.3.1 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 RESEARCH LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.1.1 SECONDARY DATA 17
2.1.2 PRIMARY DATA 18
2.2 MARKET SIZE ESTIMATION METHODOLOGY 19
2.2.1 BOTTOM-UP APPROACH 19
2.2.2 TOP-DOWN APPROACH 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.4 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 GLOBAL ORTHOBIOLOGICS MARKET OVERVIEW 27
4.2 GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT (2017 VS. 2022) 28
4.3 ORTHOBIOLOGICS MARKET: REGIONAL ANALYSIS (2017–2022) 29
4.4 ORTHOBIOLOGICS MARKET: BY APPLICATION, 2017 30
4.5 GLOBAL ORTHOBIOLOGICS MARKET SIZE, BY END USER 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 MARKET DRIVERS 33
5.2.1.1 Increasing incidence of sports injuries and road accidents 33
5.2.1.2 Increasing incidence of spinal diseases/disorders 34
5.2.1.3 Rising geriatric and obese population 34
5.2.1.4 Growing patient preference for minimally invasive procedures 35
5.2.2 MARKET RESTRAINT 36
5.2.2.1 High cost associated with orthobiologics-based treatments 36
5.2.3 GROWTH OPPORTUNITIES 36
5.2.3.1 Emerging markets 36
5.2.3.2 Increasing use of PRP in other applications 37
5.2.4 MARKET CHALLENGES 37
5.2.4.1 Lawsuits filed against major market players affecting their brand value 37
5.2.4.2 Side effects associated with BMP-based treatments 37
5.3 KEY INDUSTRY TREND 38
6 ORTHOBIOLOGICS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 VISCOSUPPLEMENTATION PRODUCTS 41
6.3 DEMINERALIZED BONE MATRICES 42
6.4 SYNTHETIC ORTHOBIOLOGICS 43
6.5 BONE MORPHOGENIC PROTEIN 44
6.6 ALLOGRAFTS 45
6.7 PLASMA-RICH PROTEIN 46
6.8 BONE MARROW ASPIRATE CONCENTRATE 47
7 ORTHOBIOLOGICS MARKET, BY APPLICATION 48
7.1 INTRODUCTION 49
7.2 OSTEOARTHRITIS AND DEGENERATIVE ARTHRITIS 50
7.3 SPINAL FUSION 51
7.4 SOFT-TISSUE INJURIES 52
7.5 FRACTURE RECOVERY 53
7.6 MAXILLOFACIAL AND DENTAL APPLICATIONS 54
8 ORTHOBIOLOGICS MARKET, BY END USER 55
8.1 INTRODUCTION 56
8.2 HOSPITALS, ORTHOPEDIC CLINICS, & AMBULATORY CARE CENTERS 57
8.3 RESEARCH & ACADEMIC INSTITUTES 58
8.4 DENTAL CLINICS AND FACILITIES 59
9 ORTHOBIOLOGICS MARKET, BY REGION 60
9.1 INTRODUCTION 61
9.2 NORTH AMERICA 62
9.2.1 US 65
9.2.2 CANADA 67
9.3 EUROPE 69
9.3.1 GERMANY 72
9.3.2 FRANCE 74
9.3.3 UK 75
9.3.4 SPAIN 77
9.3.5 ITALY 78
9.3.6 REST OF EUROPE 80
9.4 ASIA PACIFIC 81
9.4.1 JAPAN 85
9.4.2 CHINA 86
9.4.3 INDIA 87
9.4.4 REST OF ASIA PACIFIC 89
9.5 REST OF THE WORLD 91
10 COMPETITIVE LANDSCAPE 95
10.1 GLOBAL ORTHOBIOLOGICS MARKET RANKING, 2016 95
11 COMPANY PROFILES 96
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 DEPUY SYNTHES (A SUBSIDIARY OF JOHNSON & JOHNSON) 96
11.2 MEDTRONIC PLC. 100
11.3 STRYKER CORPORATION 103
11.4 ZIMMER BIOMET HOLDINGS, INC. 106
11.5 HARVEST TECHNOLOGIES CORPORATION (A TERUMO BCT COMPANY) 111
11.6 GLOBUS MEDICAL, INC. 114
11.7 ORTHOFIX INTERNATIONAL N.V. 117
11.8 RTI SURGICAL, INC. 120
11.9 K2M GROUP HOLDINGS, INC. 126
11.10 KUROS BIOSCIENCES LTD. 129
11.11 BIOVENTUS LLC 132
11.12 NUVASIVE, INC. 135
11.13 SEASPINE HOLDINGS CORPORATION 138
11.14 ARTHREX, INC. 141
11.15 XTANT MEDICAL HOLDINGS, INC. 144
*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 148
12.1 DISCUSSION GUIDE 148
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 153
12.4 AVAILABLE CUSTOMIZATIONS 154
12.5 RELATED REPORTS 155
12.6 AUTHOR DETAILS 156